Literature DB >> 8591641

Secondary post partum haemorrhage due to uterine wound dehiscence.

J V Larsen1, K Janowski, A Krolilowski.   

Abstract

BACKGROUND: Secondary post partum haemorrhage due to uterine scar dehiscence is a potentially life threatening complication of caesarean section. It is of special importance in any population with a high caesarean section rate. CASES: Two illustrative cases are described. Both presented with life threatening haemorrhage about four weeks after delivery by lower segment caesarean section. One was successfully managed with uterine wound debridement and resuture. The other required total abdominal hysterectomy.
CONCLUSIONS: This cause of post partum haemorrhage must be considered in any patient who presents with heavy bleeding in the puerperium following caesarean section. These patients should always be admitted to hospital, and the uterine wound should be palpated after dilation of the cervix at examination under anaesthesia. Laparotomy and repair or hysterectomy is essential if a defect can be felt in the wound. The choice of procedure is discussed in the text.

Entities:  

Mesh:

Year:  1995        PMID: 8591641

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  3 in total

1.  The tip of the iceberg: Post caesarean wound dehiscence presenting as abdominal wound sepsis.

Authors:  Kaundinya Kiran Bharatam; P K Sivaraja; N J Abineshwar; Vasundhara Thiagarajan; D A Thiagarajan; Sudeep Bodduluri; K B Sriraman; A Vasantha Ragavan; Shanmuga Priya
Journal:  Int J Surg Case Rep       Date:  2015-02-11

2.  Rare complications of cesarean scar.

Authors:  Divyesh Mahajan; Mandeep Kang; Manavjit Singh Sandhu; Vanita Jain; Naveen Kalra; Niranjan Khandelwal
Journal:  Indian J Radiol Imaging       Date:  2013-07

Review 3.  Etiology of Cesarean Uterine Scar Defect (Niche): Detailed Critical Analysis of Hypotheses and Prevention Strategies and Peritoneal Closure Debate.

Authors:  Shashikant L Sholapurkar
Journal:  J Clin Med Res       Date:  2018-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.